Non-Hodgkin's Lymphoma

Links shared publicly online about this topic.

  • 677
    total visits

Non-Hodgkin's Lymphoma

chw.org

Pediatricians at Children

View full resource at chw.org

Tags: Cancer, Lymphoma, Non-Hodgkin Lymphoma, Children's Health, Pediatrician

  • Share

Most Recently Shared on December 5, 2010 at 9:30 pm By:

Roche_com Roche

60% of lymphomas are non-Hodgkin lymphomas http://bit.ly/gppJxQ #ASH2010 ^lc

1 year ago...

Dr. Dunleavy Discusses Treatment Options for PMBL

onclive.com — “Dr. Kieron Dunleavy, from the National Cancer Institute, Discusses Treatment Options for Primary Mediastinal B Cell LymphomaView full resource at onclive.com

  • View Related
  • Share

Most Recently Shared on April 16, 2012 at 4:47 pm By:

ONClive Editor Oncology

Dr. Kieron Dunleavy, from the National Cancer Institute, Discusses Treatment Options for PMBL http://t.co/MhbpZoBG #OncLiveTV

2 weeks ago...

Chemo Brain: It is Real

cancer.org — “Chemo Brain: It is RealView full resource at cancer.org

  • View Related
  • Share

Most Recently Shared on April 11, 2012 at 1:08 pm By:

DrAnasYounes Anas Younes, M.D. Doctor, Internist, Oncologist, and Physician

Chemo Brain is real. Find out what causes it and what can patients do about it. http://t.co/k7Wtq28J

2 weeks ago...

T-Cell Lymphoma Clinic Trials - YouTube

youtube.com — “Our mission is to improve the cure rate of patients with PTCL and reduce treatment-related toxicity by developing novel targeted therapy using rationally des...View full resource at youtube.com

  • View Related
  • Share

Most Recently Shared on April 10, 2012 at 11:50 pm By:

DrAnasYounes Anas Younes, M.D. Doctor, Internist, Oncologist, and Physician

T cell lymphoma Program at MDACC offers innovative clinical trials... http://t.co/Dgc99sKT

3 weeks ago...

Lung Cancer Drug Requires Monitoring Of Testosterone Levels

medicalnewstoday.com — “Men experience a marked drop in their testosterone levels when taking a targeted therapy to control a specific type of lung cancer. That's according to a University of Colorado Cancer Center studyView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on April 10, 2012 at 7:05 am By:

mnt_leukemia MNT Leukemia Health News

Lung Cancer Drug Requires Monitoring Of Testosterone Levels http://t.co/quU5Tdw8 #lymphoma #leukemia

3 weeks ago...

Dr. Bart Scott: Why I Became a Doctor - Patient Power

patientpower.info — “As a medical oncologist at Seattle Cancer Care Alliance (SCCA), Dr. Bart Scott truly understands the impact of a cancer diagnosis. But for Dr. Scott, treating cancer is not just his career passion, it’s also deeply personal. After losing his mother to breast cancer while he was in middle school, Dr. Scott was diagnosed with Hodgkin lymphoma at just 22 years old. Dr. Scott’s personal experience gave life a whole new meaning and led him to do what he does today. His treatment regimen included chemView full resource at patientpower.info

  • View Related
  • Share

Most Recently Shared on April 5, 2012 at 5:55 pm By:

patientpower Andrew Schorr Support

Dr. Bart Scott: Why I Became a Doctor - Patient Power - http://t.co/JZC04xR1

3 weeks ago...

Investigational targeted drug induces responses in aggressive lymphomas, April 2, 2012 News Release - National Institutes of Health (NIH)

nih.gov — “Preliminary results from clinical trials in a subtype of lymphoma show that for a number of patients whose disease was not cured by other treatments, the drug ibrutinib can provide significant anti-cancer responses with modest side effects. These results were presented as part of the opening plenary session at the American Association of Cancer Research (AACR) Annual Meeting 2012 on April 1 by researchers at the National Cancer Institute (NCI), part of the National Institutes of Health, and collView full resource at nih.gov

  • View Related
  • Share

Most Recently Shared on April 2, 2012 at 1:16 pm By:

NIHforHealth NIH for Health

News: Investigational targeted drug induces responses in aggressive lymphomas http://t.co/k15ySoFZ

4 weeks ago...

Reduced-intensity conditioning allogeneic stem cel... [Ann Oncol. 2012] - PubMed - NCBI

ncbi.nlm.nih.gov — “PubMed comprises more than 21 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.View full resource at ncbi.nlm.nih.gov

  • View Related
  • Share

Most Recently Shared on March 29, 2012 at 4:38 pm By:

JanCernyMDPhD JanCerny, MD, PhD Oncologist, Hematologist, Physician, Doctor, PhD, and Internist

RT @transplant_doc: ~50%patients with relapsed mantle cell lymphoma alive & in remission 2 yrs after RIC allotransplant http://t.co/sFy5p0zK

4 weeks ago...

Primary Burkitt Lymphoma of the Chest Wall

hindawi.com — “Burkitt lymphoma (BL) originating in the skin and soft tissue at any site is exceedingly rare. This paper is about a case of primary sporadic BL that presented as an isolated, rapidly enlarging chest wall mass arising from skin and/or soft tissue in an adult. As with other BL presentations, this patient was treated with aggressive chemotherapy with central nervous system (CNS) chemoprophylaxis, but he later died because of sepsis.View full resource at hindawi.com

  • View Related
  • Share

Most Recently Shared on March 26, 2012 at 11:17 pm By:

Genetics_Wisdom Genetics OW OW Health

Primary Burkitt Lymphoma of the Chest Wall: Burkitt lymphoma (BL) originating in the skin and soft tissue at any... http://t.co/3HFac3ki

1 month ago...

Risk, Best Treatment May Be Guided By Newly Identification Acute Myeloid Leukemia Gene Mutations

medicalnewstoday.com — “An international group of researchers, including those from Moffitt Cancer Center in Tampa, Fla., have published a paper in the New England Journal of Medicine reviewing the results of a stView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on March 26, 2012 at 8:05 am By:

mnt_genetics MNT Genetics News Health News

Risk, Best Treatment May Be Guided By Newly Identification Acute Myeloid Leukemia Gene Mutations http://t.co/61v2Hw3t #genetics

1 month ago...

Cancer Cells Reprogrammed With Low Doses Of Epigenetic Drugs

medicalnewstoday.com — “Experimenting with cells in culture, researchers at the Johns Hopkins Kimmel Cancer Center have breathed possible new life into two drugs once considered too toxic for human cancer treatment. TheView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on March 26, 2012 at 7:05 am By:

mnt_leukemia MNT Leukemia Health News

Cancer Cells Reprogrammed With Low Doses Of Epigenetic Drugs http://t.co/dj68HJMj #lymphoma #leukemia

1 month ago...

British Journal of Haematology - Volume 156, Issue 6 - Burkitt Lymphoma - Wiley Online Library

onlinelibrary.wiley.com — “British Journal of Haematology - Volume 156, Issue 6 - Burkitt Lymphoma - Wiley Online LibraryView full resource at onlinelibrary.wiley.com

  • View Related
  • Share

Most Recently Shared on March 26, 2012 at 6:35 am By:

Wiley_Health Wiley Health Medical Health Site

You can now access the most recent BJH Special Issue on Burkitt's Lymphoma: http://t.co/FxeQiNsi

1 month ago...

Phytochemical Composition and Antioxidant Potential of Ruta graveolens L. In Vitro Culture Lines

hindawi.com — “Ruta graveolens L. is a medicinal plant used in traditional systems of medicine for treatment of psoriasis, vitiligo, leucoderma, and lymphomas with well-known anti-inflammatory and anticancer properties. Therefore antioxidant potential of R. graveolens (in planta and in vitro) was investigated. As antioxidants present in plant extracts are multifunctional, their activity and mechanism depends on the composition and conditions of the test system. Therefore, the total antioxidant capacity was evaView full resource at hindawi.com

  • View Related
  • Share

Most Recently Shared on March 26, 2012 at 12:00 am By:

Psoriasis_OW Psoriasis OW OW Health

Phytochemical Composition and Antioxidant Potential of Ruta graveolens L. In Vitro Culture Lines: Ruta graveolen... http://t.co/xVnAmuqK

1 month ago...

Oncology News - Hodgkins lymphoma RNA-transfected dendritic cells induce cancer/testis antigen-specific immune responses |3984547

mdlinx.com — “Oncology Medical Article: Hodgkins lymphoma RNA-transfected dendritic cells induce cancer/testis antigen-specific immune responsesView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on March 23, 2012 at 5:05 pm By:

MDLinx Sandeep Pulim MD Physician, Doctor, and Health Communicator

Hodgkins lymphoma RNA-transfected dendritic cells induce cancer/testis antigen-specific immune respons... http://t.co/JWSPKX3H #oncology

1 month ago...

Dr. Dunleavy Discusses ABC DLBCL Research

onclive.com — “Dr. Kieron Dunleavy, from the National Cancer Institute, Discusses ABC DLBCL ResearchView full resource at onclive.com

  • View Related
  • Share

Most Recently Shared on March 23, 2012 at 5:01 pm By:

ONClive Editor Oncology

Dr. Kieron Dunleavy, from the National Cancer Institute, Discusses ABC DLBCL Research http://t.co/N8OBDf8S #OncLiveTV

1 month ago...

Alisa Kleybanova wins in return from Hodgkin's Lymphoma at Sony Ericsson Open - News | FOX Sports on MSN

msn.foxsports.com — “Alisa Kleybanova of Russia won the first match shes played since being diagnosed with Hodgkins Lymphoma last May at the Sony Ericsson Open on Tuesday. Alisa Kleybanova wins in return from Hodgkins Lymphoma at Sony Ericsson OpenView full resource at msn.foxsports.com

  • View Related
  • Share

Most Recently Shared on March 23, 2012 at 4:04 pm By:

ASH_hematology ASH Health Organization and Hematology

RT @lymphoma: Tennis Pro Alisa Kleybanova wins first match since being diagnosed with hodgkin #lymphoma http://t.co/XhYG1iye via @FOXSports

1 month ago...

Advertisement